Cleared Traditional

K904264 - MODEL SW-103 SOLITANS STIMULATOR

K904264 is an FDA 510(k) clearance for MODEL SW-103 SOLITANS STIMULATOR, manufactured by Medical Consultants Intl. , Ltd.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 233-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1991
Decision
233d
Days
Class 2
Risk

K904264 is an FDA 510(k) clearance for the MODEL SW-103 SOLITANS STIMULATOR. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Medical Consultants Intl. , Ltd. (Glen Rock, US). The FDA issued a Cleared decision on May 9, 1991 after a review of 233 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K904264

510(k) Number K904264 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 18, 1990
Decision Date May 09, 1991
Days to Decision 233 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
84d slower than avg
Panel avg: 149d · This submission: 233d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 605
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K904264.
MENS-O-MATIC 3000
K904260 · Monad Corp. · May 1991
MENS-O-MATIC 1XS AND MENS-O-MATIC 2XS
K904288 · Monad Corp. · May 1991
MENS FREEDOM MICRO
K904430 · Monad Corp. · May 1991
GLOBALCARE MICRO 11 AND MICROCARE (TENS)
K903394 · Globalcare Intl., Inc. · May 1991
DIAL-AWAY PAIN
K904457 · R.F.P., Inc. · Apr 1991
MC II (TM), MODEL 7200S
K903161 · Medical Devices, Inc. · Mar 1991